Caplin Point Laboratories LimitedNSE: CAPLIPOINT

Press Release Feb 28 2026

Feb 28, 2026 at 11:57 AM EST · Issued by Caplin Point Laboratories Limited

Filed with NSE · Feb 28, 2026 at 11:57 AM EST · 3 pages · English

On 6ix: 6ix.com/news/press-release-feb-28-2026-2

Release

Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated February 28, 2026, titled "Receipt of final approval by our Subsidiary, Caplin Steriles Limited, from the USFDA for the Desmopressin Acetate Injection USP".

Caplin Point Laboratories Limited on 6ix

Earlier from Caplin Point Laboratories

Press Release Feb 24 2026Feb 24
Press Release Jan 27 2026Jan 27
Press Release Oct 23 2025Oct 23, 2025
Press Release Sep 03 2025Sep 3, 2025
Press Release May 14 2025May 14, 2025

Later from Caplin Point Laboratories

Press Release Mar 13 2026Mar 13
Press Release May 05 2026May 5
Press Release May 14 2026May 14

All Caplin Point Laboratories news releases

Follow Caplin Point Laboratories into a list and get an email when it puts out news.

Follow Caplin Point Laboratories